Spanish biotechnology makes up 2.8% of global production and is cited 30% more than the global average in this area. Spain is ranked 9th in scientific production in biotechnology and has the highest percentage of scientific papers in high-impact journals of any country: 83.3%.
In 2018, the biotechnology sector invested nearly €770 million in R&D, 71% from biotech companies. Biotech companies were ranked first in Spain in 2018 for R&D investment in industrial sectors, surpassing the pharmaceutical sector for the first time. The year-on-year increase in R&D investment in 2018 was 13%, among the five fastest-growing sectors in R&D investment in Spain.
AseBio Investor Day is the leading event allowing Spanish innovative biotechnology projects to be introduced to an audience of leading international investors and pharmaceutical & industrial companies.
The event is organized by AseBio, the Spanish Bioindustry Association. EuropaBio members are entitled to a discount (please liaise with Martina Cilia for more information: m.cilia@europabio.org).
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.